CorFlow Therapeutics AG: CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023
Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI CorFlow Therapeutics AG, a clinical-stage